Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

Giuliani was founded in 1889 and is a privately-held specialty pharmaceutical company focused on gastroenterology and dermatology. Currently, it markets proprietary products for the treatment and management of ulcerative colitis, Crohn's disease, food intolerances, and dermatological disorders. Giuliani's R&D pipeline consists of new chemical entities and biotechnological products that target inflammatory and autoimmune diseases.

Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ.

Takasago International Corp. engages in the manufacture and sale of flavors, fragrances, aroma ingredients, and fine chemicals. It operates through the following regional segments: Japan, America, Europe, and Asia. All of the segments handle flavor, fragrances, and aroma ingredients. The Japan segment also deals with fine chemicals and offer real estate leasing and other services. The America Segment also sells fine chemicals. The company was founded by Nanko Kaisho on February 09, 1920 and is headquartered in Tokyo, Japan.

Ranbaxy Laboratories Limited, a pharmaceutical company, produces a range of generic medicines. The company has a presence in 49 countries, manufacturing facilities in 11 countries and serves customers in approximately 125 countries. Products The company manufactures and markets generic pharmaceuticals, value added generic pharmaceuticals, branded generics, active Pharmaceuticals (API) and intermediates. Its product basket of approximately 5,000 SKUs available in approximately 125 countries worldwide, encompasses a therapeutic mix covering a majority of the chronic and acute segments. Research & Development The company offers value added formulations based on its Novel Drug Delivery System (NDDS) and New Chemical Entity (NCE) research outcomes. Novel Drug Delivery Systems (NDDS): The company's NDDS focus is mainly on the development of New Drug Applications (NDA) / Abbreviated New Drug Applications (ANDAs) of oral controlled- release products for the regulated markets. Ranbaxy's in-house NDDS programs are primarily focused on the oral segment. Inhalation (patented devices) and trans-dermal (patented adhesive polymers) programs are also being pursued through collaborations. In the oral NDDS space, Ranbaxy has developed four platform technologies namely Gastro Retentive, Modified Matrix, Multiparticulate and AeroGel. New Drug Discovery Research (NDDR): The company's NDDR program focuses on select therapeutic segments of Infectious diseases, Metabolic diseases, Inflammatory/ Respiratory disease and Oncology. The company has 8-10 programs in the area of NDDR. For Arterolane (potential Anti-malarial candidate), the company has obtained approval from the Drug Controller General of India to initiate Phase III human clinical trials in India. The company is also profiling DPP-IV Inhibitors (Di-Peptidyl Peptidase IV Inhibitors) for Type-2-diabetes, a selective Phosphodiesterase 4-b inhibitor for COPD and Asthma, and a novel antibiotic antibacterial for Community Acquired Respiratory Tract Infection. Under an alliance with an academic institution in India, various medicinal plants are being evaluated as potential sources for novel pharmaceutical agents. The company also has collaborative research projects with other academic institutions in India in the area of Respiratory and Infectious disease. Significant Events In June 2008, Ranbaxy entered into an alliance with Daiichi Sankyo Company Ltd., to create a generic pharmaceutical powerhouse. On September 17, 2009, Ranbaxy Laboratories Ltd. has entered into a strategic in-licensing agreement for the Indian market with Medy-Tox Inc. for its cosmetic product, Neuronox. Neuronox is a botulinum toxin type A complex (100 Units) pharmaceutical manufactured by Medy-Tox. History Ranbaxy Laboratories Limited was founded in 1961.

China State Institute of Pharmaceutical Industry is a company headquartered in Shanghai, China and ultimately controlled by the Government of China. The firm regulates pharmaceutical companies.

Imperial Chemical Industries (ICI) was a British chemical company and was, for much of its history, the largest manufacturer in Britain. It was formed by the merger of leading British chemical companies in 1926. Its headquarters were at Millbank in London, and it was a constituent of the FT 30 and later the FTSE 100 indices.

Tianjin Famoxi Pharmaceutical Technology Co., Ltd., established on 2008-09-24, Business scope includes biotechnology,medical technology(Except narcotic drugs and psychotropic substances),development of chemical technology,consult,Serve;Chemical Products(Dangerous goods and precursor drugs are excluded),Sodium silicate(water glass)Wholesale and retail;Import and export of goods and technology(law,Except as otherwise provided by administrative regulations);Pharmaceutical Intermediates(Hazardous chemicals and precursor drugs are excluded)Manufacturing and sales;Computer Network Technology Consulting Services;Medical Device Sales;Hazardous chemicals without storage operation(Subject to the scope of the hazardous chemicals business license).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

FARMAK is a chemical-pharmaceutical company based in Olomouc.

R.J. Reynolds Tobacco Co. manufactures and markets tobacco products. The firm has tobacco-sheet manufacturing operations and a research-and-development facility in Winston-Salem. Its brands include Camel, Kool, Pall Mall, Winston, Doral, Barclay, Lucky Strike, and Monarch. The company was founded in 1875 and is headquartered in Winston-Salem, NC.

Vontron Technology Co., Ltd. engages in the research, development, manufacture, and sale of filtration membranes. It offers composite reverse osmosis membranes, nanofiltration membranes, ultrafiltration membranes, plant fiber elastic materials, environmentally friendly furniture and bedding, palm comprehensive development products, membrane separation, and water reuse. The company was founded in 1966 and is headquartered in Guiyang, China.

Suntory Holdings Ltd. operates as a holding company with interests in the production and distribution of alcoholic and non-alcoholic beverages, health, beauty, and processed food products. Its services include formulation and promotion of group wide management strategies and corporate functions; sale of alcoholic beverages such as whiskey, beer, and wine; soft drinks; and other beverages such as tea and canned coffee. The company was founded by Shinjiro Torii in 1899 and is headquartered in Osaka, Japan.

Jiaxing Hesheng Biological Products Co., Ltd., established on 1997-09-02, The business scope includes flavonoid products,Beta products,Diuretic organic chemical raw materials,Purification and processing of organic intermediates(Does not contain drugs,Hazardous Chemicals,precursor chemicals,chemical reagent);Production of water purifiers,research and development(Free of hazardous chemicals and precursor chemicals);transport of goods by road.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Henkel AG & Co. KGaA engages in the production, sale, and distribution of home and beauty care products. The firm also provides adhesive technology solutions. It operates through the Adhesive Technologies and Consumer Brands segments. The Adhesive Technologies segment sells adhesives, sealants, and functional coatings for consumers, craftsmen, and industrial applications. The Consumer Brands segment offers branded products for consumers and professional applications for the hairdressing business that includes products for hair care, styling and coloring, as well as detergents and fabric softeners. The company was founded by Fritz Henkel on September 26, 1876 and is headquartered in Dusseldorf, Germany.

Gill Polypeptide Biopharmaceutical (Dalian) Co., Ltd., established on 2009-11-16, Business scope includes pharmaceutical production,food production,amino acid,polypeptide,Nucleotide,Fine Chemicals(None of the above contain hazardous chemicals)research and development,production and sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Raffles PharmaTech Co., Ltd. develops and manufactures pharmaceutical ingredients and intermediates. Its services include contract lab synthesis, process development, and manufacturing services. The firm’s products include API’s, intermediates, organic catalysts, and impurity reference. The company was founded in 2011 and is headquartered in Huizhou, China.

Time Wharton Technology Co., Ltd., established on 2006-07-28, Business scope includes legal,regulations,Those prohibited by the State Council's decision shall not operate;law,regulations,The State Council has decided to allow(approval)of,After approval by the examination and approval authority(approval)file management;law,regulations,The State Council has decided that a license is not required(approval)of,Market entities independently choose to operate.(Composite reverse osmosis membrane,Research and development of nanofiltration membranes and other membrane separation materials,Production,Sales and technical service;drinking water,pure water,Desalination plant for seawater and brackish water treatment,Industrial water,Design of Sewage Treatment Equipment,Production,Sales and technical service;Polymer Materials,Research and development of polymer additives,Production,Sales and technical service;Undertake water treatment engineering and technical consulting services,Promotion and Transfer;Carry out import and export business of technology and materials(Except for national special projects);Membrane separation technology development,Membrane separation product design;Investment and investment management in the field of water affairs and new materials.Sales:Electronic Component,Equipment,Wujinjiaodian,electronic product,Chemical Products(Dehazardous chemicals).Involved in licensing projects,It should be operated after obtaining the permission of the relevant department)

Shandong Chuancheng Pharmaceutical Co., Ltd., established on 2014-01-06, Business scope includes licensed projects:pharmaceutical production;Drug import and export;Drug retail.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Pharmaceutical commissioned production;Biochemical product technology research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals);Chemical product production(No licensed chemical products);Import and export;Domestic trade agent.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Suzhou Lakeside Pharmaceutical Co., Ltd., established on 2009-09-28, Business scope includes pharmaceutical intermediates,R&D and sales of raw materials;Provide technical consulting services;Engaged in the wholesale of pharmaceutical intermediates and the import and export of related products and technologies(Commodities that do not involve state trade management,Quota involved,of license-managed goods,Apply in accordance with relevant national regulations),Undertake the service outsourcing business of domestic and foreign pharmaceutical companies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)